In a wide-ranging video interview, Wendie Berg, MD, PhD, discussed her family history with breast cancer, the founding of DenseBreast-info.org, emerging research with contrast-enhanced mammography and the need for a national standard on breast density notifications.
For Wendie Berg, MD, PhD, FACR, FSBI, conducting and disseminating research and education on breast cancer screening has been a driving force in her career and a personal mission as well. Her mother had breast cancer, her aunt had breast cancer and Dr. Berg is a breast cancer survivor. In a recent interview, Dr. Berg emphasized the importance of timely supplemental breast imaging in women with dense breasts.
“It’s very hard when you see a patient who has a cancer that is larger than it needed to be that wasn’t seen on a recent mammogram, and she didn’t know she had dense breasts and didn’t know she could have had additional screening that could have found the cancer earlier,” noted Dr. Berg, a professor of radiology at the University of Pittsburgh. “I’m trying to reduce that from happening to other women.”
In April 2015, Dr. Berg co-founded www.DenseBreast-info.org, which provides patient-oriented and provider-focused resources on dense breasts, a key risk factor for the development of breast cancer. On the recent World Dense Breast Day (September 28, 2022), Dr. Berg said the website had a reach of over 8 million people on social media platforms with visits from 37 countries and over 17,000 content engagements.
One of the leading researchers on breast imaging, Dr. Berg said contrast-enhanced mammography is a promising advance that can help detect breast cancer that may not be apparent on digital mammography. She also noted that contrast-enhanced mammography has practical advantages as it can be performed with existing equipment, minimal software upgrades and contrast that is inexpensive.
For more insights from Dr. Berg, watch the video below.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.